US 11236171
Human monoclonal antibodies specific for FLT3 and uses thereof
granted A61KA61K2039/505A61K47/6849
Quick answer
US patent 11236171 (Human monoclonal antibodies specific for FLT3 and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/505, A61K47/6849, A61K47/6929, A61P